
Acuzid TZ 250mg/31.25mg Injection
Marketer
Alive Healthcare
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Acuzid TZ 250mg/31.25mg Injection
Tazicef 250mg/31.25mg injectable solution is a dual-action antibiotic. It's indicated for treating diverse bacterial infections by inhibiting microbial growth and propagation. Administration of Tazicef 250mg/31.25mg Injection must be overseen by a medical professional. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, even with symptom improvement. Premature cessation may compromise treatment efficacy. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea), and dyspepsia. Worsening side effects necessitate immediate medical consultation. Seek prompt medical attention for any allergic reaction (e.g., skin rashes, pruritus, edema, respiratory distress). Inform your physician of all concurrent medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, a nutritious diet, and hydration contribute to faster recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Uses of Acuzid TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Acuzid TZ 250mg/31.25mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Acuzid TZ 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Acuzid TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Acuzid TZ 250mg/31.25mg Injection works:
Ceftazidime and Tazobactum, combined as Acuzid TZ 250mg/31.25mg Injection, offer a targeted antibacterial approach. Ceftazidime, an antibiotic, disrupts bacterial cell wall synthesis, hindering their survival. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Acuzid TZ 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Acuzid TZ 250mg/31.25mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Acuzid TZ (250mg/31.25mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal transfer of the drug into breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
The injection Acuzid TZ 250mg/31.25mg can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
The injectable medication Acuzid TZ 250mg/31.25mg requires careful administration for individuals with impaired kidney function. Dosage modification may be necessary. A physician's consultation is advised.
LiverCAUTION
The injectable medication Acuzid TZ 250mg/31.25mg requires careful administration for individuals suffering from advanced hepatic impairment. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Acuzid TZ 250mg/31.25mg Injection :
Omit Acuzid TZ 250mg/31.25mg Injection doses necessitate physician consultation.
Facts to Know About Acuzid TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
